BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Pharmacogenetics
,
Fluoxetine
,
rs2300478
,
TGFB1
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LEFTY1;jsessionid=87A7A77BCAAA0F7024E1A0695EBC8A15
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon
Colon mucosa
Duodenum
Sigmoid colon
Colon cecum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Lefty1 Ameliorates Post-infarction Fibrosis by Suppressing p-Smad2 and p-ERK1/2 Signaling Pathways.
Lefty1 and lefty2 control the balance between self-renewal and pluripotent differentiation of mouse …
Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodo…
LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis.
Zebrafish Cdx1b modulates epithalamic asymmetry by regulating ndr2 and lft1 expression.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for LEFTY1;jsessionid=87A7A77BCAAA0F7024E1A0695EBC8A15
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ